As was previously mentioned, the patient had nocturnal hypoglycemic symptoms while having low blood insulin levels; the current pelvic tumor was unquestionably the SFT because it produced IGF-II, which led to hypoglycemia. Here, IGF2 is linked to Hypoglycemia.